← Leaderboards
Jessica Jiyeong Lin
Massachusetts General Hospital
$1,690,059
Attributed
$2,305,871
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $417.5K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,305,871 · 1
By mechanism
R01$2,305,871 · 1
Top collaborators
- Aaron N Hata3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Daniel A. Haber$29,412,047
- Aaron N Hata$5,868,906
- Ben Z Stanger$14,778,829
- Alice T Shaw$3,731,101
- Lecia V. Sequist$4,399,201
Others in their field
Other Emerging Leaders on “Molecular Subtypes”
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Hailiang Huang · Massachusetts General Hospital$7,964,900
- Sonia Minikel Vallabh · Broad Institute, Inc.$7,643,981
- Scott Hensley · University Of Pennsylvania$6,953,187
- Corrie Ann Painter · Broad Institute, Inc.$5,899,297
- Yuichi Shimada · Columbia University Health Sciences$5,671,179
Research focus
Molecular SubtypesNext GenerationIn VitroMediatingMutationAutomobile DrivingCrizotinibGenerationsKinase InhibitorMalignant Neoplasm Of LungBypassAnaplastic Lymphoma KinaseCancer EtiologyCancer PatientClinical TrialsCombined Modality TherapyCell LineFutureCessation Of LifeIn VivoBiopsyChromosomal RearrangementClinicNon-Small-Cell Lung Carcinoma
Grant awards (6)
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors$417,500
R01 · FY2025 · CA
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors$396,625
R01 · FY2024 · CA
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors$417,500
R01 · FY2023 · CA
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors$399,380
R01 · FY2021 · CA · contact PI
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors$399,380
R01 · FY2020 · CA · contact PI
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors$275,486
R01 · FY2019 · CA · contact PI